CD8A and neoplasm: Increased MHCII pathway expression, then, likely reflects ENT‐induced changes in tumor expression profiles as well as changes in tumor cell biology that in turn promote CD8 T cell activation, subsequent increases in IFNγ production, and resultant upregulation of antigen presentation.